Newsmeme!
Discover News you didn't know existed
Vasomedical, Inc. ("Vasomedical") (OTC: VASO.OB), a leader in the noninvasive treatment and management of cardiovascular diseases, today announced financial results for its fiscal year ended May 31, 2008.
The Chief of Staff Land Forces, Brig. Charles Angina, has launched a scathing attack on army officers who resort to witchcraft to get promotions.
MANILA, Philippines—In Norway, on the way to the countryside, we passed by a “farm clinic” where horses and other farm animals are used to assist in the treatment of mental disorders such as depression, excessive anxiety and even frank psychosis.
Researchers at The University of Nottingham have been awarded £2.8 million by the Wellcome Trust to develop a new drug that could ease the suffering of hundreds of thousands of heart disease patients who are unable to take beta-blockers. In the UK, 2.
Intervention Triage strategY study, published in the September 2, 2008 issue of the Journal of American College of Cardiology, shows that Angiomax® (bivalirudin) monotherapy provides moderate- and high-risk (unstable angina (UA)/non - ST elevation myocardial infarction) acute coronary syndrome (A
Cytokinetics has completed a protocol-defined interim analysis in an ongoing Phase IIa clinical trial evaluating the safety of CK-1827452 in patients with ischemic cardiomyopathy and angina.
Cytokinetics, Incorporated announced the completion of a protocol-defined interim analysis in an ongoing phase-IIa clinical trial evaluating the safety of CK-1827452 in patients with ischemic cardiomyopathy and angina.
Dear Dr. Gott: I am 78 years old. When I was 76, I developed a cough and mucus in my throat. I have never smoked, so my doctor told me it was from allergies. I have never had allergies before. He prescribed Allegra-D, to be taken twice a day on an empty stomach.
Anthera Pharmaceuticals Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced the initiation of the FRANCIS (Fewer Recurrent Acute coronary events with Near-term Cardiovascular Inflammation Suppression) clinical trial designed to examine the impact of varespladib when administered to patients within 96 hours of an Acute Coronary Syndrome (ACS) event.
LONDON: Researchers are developing a new drug that will treat heart disease and angina without aggravating any underlying respiratory problems.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |